EGFL7 抗体 (AA 30-80) (Cy5)
Quick Overview for EGFL7 抗体 (AA 30-80) (Cy5) (ABIN733992)
抗原
See all EGFL7 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 30-80
-
纯化方法
- Purified by Protein A.
-
免疫原
- KLH conjugated synthetic peptide derived from mouse EGFL7
-
亚型
- IgG
-
-
-
-
应用备注
-
IF(IHC-P) 1:50-200
IF(ICC) 1:50-200 -
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 1 μg/μL
-
缓冲液
- Aqueous buffered solution containing 1 % BSA, 50 % glycerol and 0.09 % sodium azide.
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
储存条件
- 4 °C
-
储存方法
- Store at 4°C
-
有效期
- 12 months
-
-
- EGFL7 (EGF-Like-Domain, Multiple 7 (EGFL7))
-
别名
- Egfl7
-
背景
-
Regulates vascular tubulogenesis in vivo. Inhibits platelet-derived growth factor (PDGF)-BB-induced smooth muscle cell migration and promotes endothelial cell adhesion to the extracellular matrix and angiogenesis.
Subcellular location: Secreted
Synonyms: Zneu1, VE-statin, Epidermal growth factor-like protein 7, EGF-like protein 7, Multiple epidermal growth factor-like domains protein 7, Multiple EGF-like domains protein 7, NOTCH4-like protein, Vascular endothelial statin, Egfl7, Megf7
-
基因ID
- 353156
-
UniProt
- Q9QXT5
抗原
-